With drugs and $120M, Peninsula biotech emerges with focus on immune-mediated diseases
HI-Bio is focusing on autoimmune, allergic, inflammatory and other diseases where immune system players go bad cause diseases.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Ron Leuty Source Type: news
More News: Allergy & Immunology | Autoimmune Disease | Biotechnology | Health Management | Pharmaceuticals